Cocrystal Pharma, Inc.
COCP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $14 | $15 | $14 | $21 |
| - Cash | $8 | $5 | $7 | $10 |
| + Debt | $2 | $2 | $2 | $2 |
| Enterprise Value | $8 | $12 | $9 | $12 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$2 | -$2 | -$2 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$2 | -$2 | -$2 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.2 | -0.23 | -0.32 |
| % Growth | 5% | 13% | 28.1% | – |
| Operating Cash Flow | -$2 | -$2 | -$3 | -$3 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$2 | -$2 | -$3 | -$3 |